Oak Street Health, Inc. (OSH)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Oak Street Health, Inc. (“Oak Street” or the “Company”) (NYSE: OSH). The investigation concerns whether Oak Street and certain of its officers and/or directors have violated federal securities laws.
On November 8, 2021, Oak Street filed its quarterly report with the U.S. Securities and Exchange Commission for the third quarter of 2021. Among other items, Oak Street disclosed that “[o]n November 1, 2021, the Company received a civil investigative demand (‘CID’) from the United States Department of Justice. According to the CID, the Department of Justice is investigating whether the Company may have violated the False Claims Act, 31 U.S.C. §§ 3729-3722. The CID requests certain documents and information related to the Company’s relationships with third-party marketing agents and related to the Company’s provision of free transportation to federal health care beneficiaries and requests information and documents related to such matters.” On this news, Oak Street’s stock price fell $9.75 per share, or 20.79%, to close at $37.14 per share on November 9, 2021.
If you are aware of any facts relating to this investigation, or purchased Oak Street shares, you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.